Mismatch Repair-Dependent Transcriptome Changes in Human Cells Treated with the Methylating Agent N-Methyl-N′-Nitro-N-Nitrosoguanidine

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8158-8166

  Di Pietro, Massimiliano ^a   Marra, Giancarlo ^a   Cejka, Petr ^a   Stojic, Lovorka ^a   Menigatti, Mirco ^a   Cattaruzza, Maria Sofia ^b   Jiricny, Josef ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; GROWTH INHIBITOR; METHYLNITRONITROSOGUANIDINE; PROTEIN MLH1; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; EMBRYO; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; METAPHASE; MISMATCH REPAIR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

B-LYMPHOCYTES; BASE PAIR MISMATCH; CARRIER PROTEINS; CELL LINE; DNA METHYLATION; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; METHYLNITRONITROSOGUANIDINE; MUTATION, MISSENSE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0347626103     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Karran, P., and Bignami, M. Drug-related killings: a case of mistaken identity. Chem. Biol., 3: 875-879, 1996.
2. Brauch, P., Aquilina, G., Bignami, M., and Karran, P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature (Lond.). 362: 652-654, 1993.
3. Kat, A., Thilly, W. G., Fang, W. H., Longley, M. J., Li, G. M., and Modrich, P. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA. 90: 6424-6428, 1993.
4. Koi, M., Umar, A., Chauhan, D. P., Cherian, S. P., Carethers, J. M., Kunkel, T. A., and Boland, C. R. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′ -nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res., 54: 4308-4312, 1994.
5. 2 cell cycle checkpoint. Cancer Res., 55: 3721-3725, 1995.
6. Marra, G., and Schaer, P. Recognition of DNA alterations by the mismatch repair system. Biochem. J., 338: 1-13, 1999.
7. 2-M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J., 22: 2245-2254, 2003.
8. Jass, J. R., Whitehall, V. L., Young, J., and Leggett, B. A. Emerging concepts in colorectal neoplasia. Gastroenterology, 123: 862-876, 2002.
9. D'Atri, S., Tentori, L., Lacal, P. M., Graziani, G., Pagani, E., Benincasa, E., Zambruno, G., Bonmassar, E., and Jiricny, J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol., 54: 334-341, 1998.
10. Hickman, M. J., and Samson, L. D. Role of DNA-mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA, 96: 10764-10769, 1999.
11. Duckett, D. R., Bronstein, S. M., Taya, Y., and Modrich, P. hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage. Proc. Natl. Acad. Sci. USA, 96: 12384-12388, 1999.
12. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., and Calos, M. P. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol., 7: 379-387, 1987.
13. Trojan, J., Zeuzem, S., Randolph, A., Hemmerle, C., Brieger, A., Raedle, J., Plotz, G., Jiricny, J., and Marra, G. Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system. Gastroenterology, 122: 211-219, 2002.
14. Goldmacher, V. S., Cuzick, R. A. J., and Thilly, W. G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnitrosourea and N-methyl-N′ -nitro-N-nitrosoguanidine. J. Biol. Chem., 261: 12462-12471, 1986.
15. Papadopoulos, N., Nicolaides, N. C., Liu, B., Parsons, R., Lengauer, C., Palombo, F., D'Arrigo, A., Markowitz, S., Willson, J. K., Kinzler, K. W., and Vogelstein, B. Mutations of GTBP in genetically unstable cells. Science (Wash. DC), 268: 1915-1917, 1995.
16. Xia, F., Wang, X., Wang, Y. H., Tsang, N. M., Yandell, D. W., Kelsey, K. T., and Liber, H. L. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res., 55: 12-15, 1995.
17. Pelengaris, S., Khan, M., and Evan, G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer, 2: 764-776, 2002.
18. Ten Dijke, P., Goumans, M. J., Itoh, F., and Itoh, S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol., 191: 1-16, 2002.
19. Beere, H. M., and Green, D. R. Stress management: heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol., 11: 6-10, 2001.
20. Okuyama, T., Ishihara, S., Sato, H., Rumi, M. A., Kawashima, K., Miyaoka, Y., Suetsugu, H., Kazumori, H., Cava, C. F., Kadowaki, Y., Fukuda, R., and Kinoshita, Y. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines. J. Lab. Clin. Med., 140: 92-102, 2002.
21. Landberg, G., Ostlund, H., Nielsen, N. H., Roos, G., Emdin, S., Burger, A. M., and Seth, A. Down-regulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene, 20: 3497-3505, 2001.
22. Fan, F., Jin, S., Amundson, S. A., Tong, T., Fan, W., Zhao, H., Zhu, X., Mazzacurati, L., Li, X., Petrik, K. L., Fornace, A. J., Jr., Rajasekaran, B., and Zhan, Q. ATF3 induction following DNA damage is regulated by distinct signaling pathways and overexpression of ATF3 protein suppresses cells growth. Oncogene, 21: 7488-7496, 2002.
23. Jelinsky, S. A., and Samson, L. D. Global response of Saccharomyces cerevisiae to an alkylating agent. Proc. Natl. Acad. Sci. USA, 96: 1486-1491, 1999.
24. Chen, D., Toone, W. M., Mata, J., Lyne, R., Burns, G., Kivinen, K., Brazma, A., Jones, N., and Bahler, J. Global transcriptional responses of fission yeast to environmental stress. Mol. Biol. Cell, 14: 214-229, 2003.
25. Kannan, K., Amariglio, N., Rechavi, G., Jakob-Hirsch, J., Kela, I., Kaminski, N., Getz, G., Domany, E., and Givol, D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene, 20: 2225-2234, 2001.
26. Adimoolam, S., and Ford, J. M. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. USA, 99: 12985-12990, 2002.
27. Hwang, B. J., Ford, J. M., Hanawalt, P. C., and Chu, G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA, 96: 424-428, 1999.
28. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis. Nature (Lond.), 389: 300-305, 1997.
29. Vousden, K. H., and Lu, X. Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2: 594-604, 2002.
30. Nakano, K., and Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell., 7: 683-694, 2001.
31. Yu, J., Wang, Z., Kinzler, K. W., Vogelstein, B., and Zhang, L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. USA, 100: 1931-1936, 2003.
32. Fulda, S., and Debatin, K. M. IFN-γ sensitizes for apoptosis by up-regulating caspase-8 expression through the Stat1 pathway. Oncogene, 21: 2295-2308, 2002.
33. Guzman-Rojas, L., Sims-Mourtada, J. C., Rangel, R., and Martinez-Valdez, H. Life and death within germinal centres: a double-edged sword. Immunology, 107: 167-175, 2002.
34. Ashkenazi, A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer, 2: 420-430, 2002.
35. 1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol., 13: 738-747, 2001.
36. Bendjennat, M., Boulaire, J., Jascur, T., Brickner, H., Barbier, V., Sarasin, A., Fotedar, A., and Fotedar, R. UV irradiation triggers ubiquitin-dependent degradation of p21/WAF1 to promote DNA repair. Cell, 114: 599-610, 2003.
37. Javelaud, D., and Besancon, F. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio. J. Biol. Chem., 277: 37949-37954, 2002.
38. Zhang, Y., Fujita, N., and Tsuruo, T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene, 18: 1131-1138, 1999.
39. Naot, D., Sionov, R. V., and Ish-Shalom, D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res., 71: 241-319, 1997.
40. Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N., and Adams, J. C. Fascins, and their roles in cell structure and function. Bioessays, 24: 350-361, 2002.
41. Steegenga, W. T., van Laar, T., Riteco, N., Mandarino, A., Shvarts, A., van der Eb, A. J., and Jochemsen, A. G. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol., 16: 2101-2109, 1996.
42. Pipas, J. M., and Levine, A. J. Role of T antigen interactions with p53 in tumorigenesis. Semin. Cancer Biol., 11: 23-30, 2001.
43. Nishihara, A., Hanai, J., Imamura, T., Miyazono, K., and Kawabata, M. E1A inhibits transforming growth factor-β signaling through binding to Smad proteins. J. Biol. Chem., 274: 28716-28723, 1999.
44. Shaulian, E., and Karin, M. AP-1 as a regulator of cell life and death. Nat. Cell Biol., 4: E131-E136, 2002.
45. Sanchez-Perez, I., Martinez-Gomariz, M., Williams, D., Keyse, S. M., and Perona, R. CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene, 19: 5142-5152, 2000.
46. Chen, Y. R., Shrivastava, A., and Tan, T. H. Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene, 20: 367-374, 2001.
47. Classon, M., and Harlow, E. The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer, 2: 910-917, 2002.
48. Lopez-Bermejo, A., Buckway, C. K., Devi, G. R., Hwa, V., Plymate, S. R., Oh, Y., and Rosenfeld, R. G. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology, 141: 4072-4080, 2000.
49. 1 and cyclin A associated apoptosis. Oncogene, 21: 140-147, 2002.